特例承認 against Huaiza K.K.

ファイザー株式会社 (医薬品医療機器等法)
医薬品医療機器等法Ministry of Health, Labour and WelfareNovember 11, 2021

Action summary

Company
Huaiza K.K.Romanized
Original: ファイザー株式会社
Corporate Number: 5011001126167
Governing law
医薬品医療機器等法
医薬品医療機器等法
Action type
特例承認
特例承認
Action date
November 11, 2021
Issuing authority
Ministry of Health, Labour and Welfare
厚生労働省

Violation

Machine-translated summary — verify against original

A special approval was granted under Article 14-3 of the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices for partial changes to the manufacturing and marketing approval of COVID-19 vaccines.

Show original Japanese text

新型コロナウイルス感染症に係るワクチンの製造販売承認事項の一部変更等について、医薬品医療機器等法第14条の3に基づく特例承認を行いました。

Source

Original Ministry of Health, Labour and Welfare announcement (in Japanese)

The original Japanese disclosure is the authoritative record.

Watch this company

Get an email when Huaiza K.K. has new enforcement actions or registry changes (representative, address, business status). Sign-in is via a one-time email link — no password.

Company info

English name
Huaiza K.K. Romanized
Japanese name
ファイザー株式会社
Corporate Number
5011001126167
Registered address
東京都渋谷区代々木3丁目22番7号
See company profile →

About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.